Two enterococcal proteins SagA and PpiC were found to be promising immunogenic carrier proteins that can be used either conjugated to DHG or to other polysaccharides to develop multivalent vaccines formulations. We have developed a glycoconjugates composed of the proteins and the surface polysaccharide DHG which presents a broad coverage against infections caused by the Enterococcus faecalis and faecium.
Addressing target audiences and expressing needs
- Grants and Subsidies
we are seeking for translating this vaccine candidate to proof of concept in humans, covering process optomization, scale up for production of GMP lot and first in human clinical trial
- Public or private funding institutions
- Research and Technology Organisations
- Academia/ Universities
R&D, Technology and Innovation aspects
the preclinical proof of principle has been demonstrated
